Description

Lanreotide represents a synthetic octapeptide developed as a long-acting analogue of somatostatin, incorporating specific modifications designed to enhance stability and extend duration of action compared to native somatostatin. The compound demonstrates high binding affinity for multiple somatostatin receptor subtypes and provides sustained receptor activation in research systems. The peptide incorporates structural modifications including D-amino acids and cyclization that contribute to enhanced resistance to enzymatic degradation and improved pharmacokinetic properties. Lanreotide functions through specific binding to somatostatin receptors (SSTR1-5), leading to inhibition of hormone secretion and modulation of cellular signaling pathways. Research applications include investigation of somatostatin biology, neuroendocrine regulation mechanisms, and the role of somatostatin signaling in various physiological processes. For research use only.